- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Denosumab – November 2018
Denosumab: Injection 120 mg in 1.7 mL; Xgeva®
Last updated
1 March 2019